Muzaffar Kayumov

12 та иш

Institute of Bioorganic Chemistry of Uzbekistan Academy of Sciences Tashkent Uzbekistan

1. Toad venom bufadienolides and bufotoxins: An updated review

   Akmal M. Asrorov, Muzaffar Kayumov, Nurkhodja Mukhamedov +8

   Шарҳ мақолаIon Transport and Channel RegulationDrug Development Research20233 иқтибос

   ABIABI:AkademIndex/openalex/2023.review-article.000028

2. Alantolactone: structural enhancements and therapeutic insights for cancer and inflammation

   Muzaffar Kayumov, Fotima A. Sobirova, Okhunjon Khasanov +3

   Шарҳ мақолаSesquiterpenes and Asteraceae StudiesNatural Product Research20253 иқтибос

   ABIABI:AkademIndex/openalex/2025.review-article.000101

3. Design, synthesis and pharmacological evaluation of new PARP1 inhibitors by merging pharmacophores of olaparib and the natural product alantolactone

   Muzaffar Kayumov, Jia Li, Azizbek Pardaev +9

   МақолаPARP inhibition in cancer therapyEuropean Journal of Medicinal Chemistry20222 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.075060

4. Synthesis and Characterisation of Chickpea Peptides-Zinc Chelates Having ACE2 Inhibitory Activity

   Nurkhodja Mukhamedov, Akmal M. Asrorov, Ansor Yashinov +5

   МақолаProtein Hydrolysis and Bioactive PeptidesThe Protein Journal20231 иқтибос

   ABIABI:AkademIndex/openalex/2023.article.000810

5. Computational and in vitro evaluation of sumac-derived ©Rutan compounds towards Sars-CoV-2 Mpro inhibition

   Muzaffar Kayumov, Parthiban Marimuthu, Jamoliddin Razzokov +8

   МақолаMedicinal Plant ResearchFrontiers in Pharmacology20251 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.000856

6. 3CLpro of SARS-CoV-2 as a new target for bufadienolides: in silico and in vitro study

   Muzaffar Kayumov, Jamoliddin Razzokov, Mukhriddin Makhkamov +10

   МақолаDrug-Induced Hepatotoxicity and ProtectionJournal of Computer-Aided Molecular Design20251 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.002111

7. A new polymorphic form of 3b,11a,14-trihydroxy-5b,14b-bufa-20,22-dienolide (telocinobufagin) and its p300 and NNMT inhibitory activity

   Muzaffar Kayumov, Nurkhodja Mukhamedov, Jamshid Ashurov +8

   МақолаSesquiterpenes and Asteraceae StudiesJournal of Molecular Structure20251 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.460196

8. Synthesis of Arylstannanes via Palladium‐Catalyzed Decarbonylative Coupling of Aroyl Fluorides

   Muzaffar Kayumov, Jiannan Zhao, Sharafitdin Mirzaakhmedov +2

   МақолаFluorine in Organic ChemistryAdvanced Synthesis & Catalysis20190 иқтибос

   ABIABI:AkademIndex/openalex/2019.article.000097

9. Albumin is a reliable drug-delivering molecule: Highlighting points in cancer therapy

   Akmal M. Asrorov, Nurkhodja Mukhamedov, Muzaffar Kayumov +5

   МақолаProtein Interaction Studies and Fluorescence AnalysisMedicine in Drug Discovery20240 иқтибос

   ABIABI:AkademIndex/openalex/2024.article.000204

10. Food Protein‐Derived Zinc‐Binding Peptides: Isolation, Purification, and Biological Aspects

    Nurkhodja Mukhamedov, Akmal M. Asrorov, Muzaffar Kayumov +4

    МақолаProtein Hydrolysis and Bioactive PeptidesPeptide Science20240 иқтибос

    ABIABI:AkademIndex/openalex/2024.article.001103

11. Tumor Microenvironment‐Responsive Nanomedicines for Potentiating Cancer Immunotherapy

    Qianqian Huang, Fan Tong, Jiantao Chen +5

    Шарҳ мақолаNanoplatforms for cancer theranosticsAdvanced Science20250 иқтибос

    ABIABI:AkademIndex/openalex/2025.review-article.000021

12. Targeted Protein Degradation and Delivery Strategies in the Context of Neurological Disorders

    Haoran Lu, Zixiao Yang, Muzaffar Kayumov +7

    МақолаProtein Degradation and InhibitorsACS Nano20260 иқтибос

    ABIABI:AkademIndex/openalex/2026.article.014466